Physician profile
Don Sheldon Fixler
NPI 1831125079
$8,958.12
in general payments reported to CMS, 2019-2025
39 companies · $1,572 in 2025
The $1,572 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,495 · 2020: $869 · 2021: $400 · 2022: $1,132 · 2023: $1,237 · 2024: $1,251 · 2025: $1,572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,060.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,180.24 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,152.49 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Astrazeneca Pharmaceuticals LP | $1,074.97 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $944.09 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $626.84 | 2019-2024 | Xarelto |
| Pfizer INC. | $520.05 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $440.13 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $406.14 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $306.35 | 2023-2025 | |
| Dexcom, INC. | $295.12 | 2021-2023 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $293.64 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Exact Sciences Corporation | $216.38 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $170.46 | 2019-2025 | Jardiance, Synjardy |
| Biohaven Pharmaceutical Holding Company LTD. | $125.10 | 2022 | |
| Grifols USA, LLC | $116.36 | 2019-2020 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Don Fixler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.